Pierre Desreumaux
Overview
Explore the profile of Pierre Desreumaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
4681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capirchio L, Rousseaux C, Dubuquoy C, Ouwehand A, Maquet V, Modica S, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409061
Chitin-glucan (CG) is a new generation of prebiotic. NCFM (NCFM) is a probiotic with the ability to decrease abdominal pain. We evaluate the functional and molecular gastrointestinal responses to a...
2.
Ait Mohand J, Alves A, Brouquet A, Germain A, Bridoux V, Trilling B, et al.
Colorectal Dis
. 2024 Sep;
26(11):1941-1949.
PMID: 39317953
Aim: The rate of surgical recurrence following ileorectal anastomosis (IRA) in patients with Crohn's disease (CD) remains poorly understood. Most studies were conducted before the advent of biologics. Our aim...
3.
Bosselaar S, Dhelin L, Dautel E, Titecat M, Duthoy S, Stelmaszczyk M, et al.
BMC Microbiol
. 2024 Jul;
24(1):233.
PMID: 38951788
Background: Inflammatory Bowel Diseases (IBD) are a major public health issue with unclear aetiology. Changes in the composition and functionality of the intestinal microbiota are associated with these pathologies, including...
4.
Zerbib P, Desreumaux P
J Visc Surg
. 2024 Jun;
161(5):291-292.
PMID: 38906787
No abstract available.
5.
Talbodec N, Le Roy P, Fournier P, Lesage B, Lepoutre E, Castex F, et al.
World J Gastrointest Pharmacol Ther
. 2024 Jun;
15(3):90757.
PMID: 38846967
Background: Irritable bowel syndrome (IBS), defined according to the Rome IV diagnostic criteria, is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain related to altered bowel habits. First-line...
6.
Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, et al.
World J Gastroenterol
. 2024 May;
30(16):2258-2271.
PMID: 38690023
Background: Irritable bowel syndrome (IBS) is one of the most frequent and debilitating conditions leading to gastroenterological referrals. However, recommended treatments remain limited, yielding only limited therapeutic gains. Chitin-glucan (CG)...
7.
Cartier L, Loiez A, Nachury M, Azahaf M, Hambli S, Blondeaux A, et al.
Inflamm Bowel Dis
. 2024 Apr;
31(1):52-62.
PMID: 38597799
Background: Crohn's disease (CD) is a progressive, destructive, and disabling disorder. Our study aimed to assess changes over time in the Lémann index (LI) and the Inflammatory Bowel Disease Disability...
8.
Blondeaux A, Valibouze C, Speca S, Rousseaux C, Dubuquoy C, Blanquart H, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396840
The therapeutic management of Crohn's disease (CD), a chronic relapsing-remitting inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a necessary procedure even though it is often associated...
9.
Bitterlin T, Valibouze C, Lenne X, Bruandet A, Desreumaux P, Zerbib P
J Crohns Colitis
. 2024 Jan;
18(7):1071-1080.
PMID: 38243563
Background And Aims: Despite the development of medical therapy, nearly 50% of patients with Crohn's disease [CD] undergo surgery during their lifetime. Several studies have suggested some risk factors for...
10.
Valibouze C, Nachury M, Hambli S, Desreumaux P, Zerbib P
Eur J Gastroenterol Hepatol
. 2023 Sep;
35(10):1230.
PMID: 37665615
No abstract available.